Murine leukemia virus (MLV) replication monitored with fluorescent proteins

BACKGROUND: Cancer gene therapy will benefit from vectors that are able to replicate in tumor tissue and cause a bystander effect. Replication-competent murine leukemia virus (MLV) has been described to have potential as cancer therapeutics, however, MLV infection does not cause a cytopathic effect...

Descripción completa

Detalles Bibliográficos
Autores principales: Sliva, Katja, Erlwein, Otto, Bittner, Alexandra, Schnierle, Barbara S
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2004
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC544597/
https://www.ncbi.nlm.nih.gov/pubmed/15610559
http://dx.doi.org/10.1186/1743-422X-1-14

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC544597/
https://www.ncbi.nlm.nih.gov/pubmed/15610559
http://dx.doi.org/10.1186/1743-422X-1-14

Ejemplares similares